Mamoru Hyodo

9.5k citations

88 papers · 7.8k indexed · 4 hit papers · h-index 39

Impact in

Immunology top 0.5%
- interferon and immune responses
- Immune Response and Inflammation
Endocrinology top 0.5%

Papers in

Endocrinology 8
Microbiology 7

Co-authors: Yoshihiro Hayakawa Hideyoshi Harashima Kathryn M. Monroe Russell E. Vance Dara Burdette Yusuke Sato Stephen Lory Katia Troha
Journals: Journal of Controlled Release (11 papers)Biological and Pharmaceutical Bulletin (5 papers)Tetrahedron (4 papers)Molecular Therapy (3 papers)Journal of Bacteriology (3 papers)
Partner nations: Japan United States Canada

In The Last Decade

Mamoru Hyodo

87 papers receiving 7.7k citations

Hit Papers

align trajectories log scale

STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation 2021 · 199 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Journal for ImmunoTherapy of Cancer
2013 Cell Reports
2011 Nature
2001 Tetrahedron

Peers

Countries citing papers authored by Mamoru Hyodo

Since Specialization

Citations

This map shows the geographic impact of Mamoru Hyodo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Hyodo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Hyodo more than expected).

Fields of papers citing papers by Mamoru Hyodo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoru Hyodo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Hyodo. The network helps show where Mamoru Hyodo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mamoru Hyodo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mamoru Hyodo Line = papers co-authored together Mamoru Hyodo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells Journal of Controlled Release ·Sofía Colias, Takashi Nakamura, Yusuke Sato, Yuki Fujiwara, Mamoru Hyodo, Hiroto Hatakeyama, Hideyoshi Harashima	2016	100
2	Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells Molecular Therapy ·Yusuke Sato, Hiroto Hatakeyama, Mamoru Hyodo, Hideyoshi Harashima	2015	74
3	Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection Journal of Hepatology ·Naoki Yamamoto, Yusuke Sato, Tsubasa Munakata, Masakazu Kakuni, Chise Tateno, Takahiro Sanada, Yuichi Hirata, Shuko Murakami, Yasuhito Tanaka, Kazuaki Chayama, Hiroto Hatakeyama, Mamoru Hyodo, Hideyoshi Harashima, Michinori Kohara	2015	60
4	“Programmed packaging” for gene delivery Journal of Controlled Release ·Mamoru Hyodo, Yu Sakurai, Hidetaka Akita, Hideyoshi Harashima	2014	20
5	c-di-GMP Enhances Protective Innate Immunity in a Murine Model of Pertussis PLoS ONE ·Shokrollah Elahi, Jill van Kessel, Sun Song-chang, Stacy Strom, Yoshihiro Hayakawa, Mamoru Hyodo, Lorne A. Babiuk, Volker Gerdts	2014	21
6	The Screening of RNA Aptamers Specific for Carbonic Anhydrase I Using the Systematic Evolution of Ligands by an Exponential Enrichment Method (SELEX) Nucleosides Nucleotides & Nucleic Acids ·Garima Shrivastava, Mamoru Hyodo, Amelia Maria Brito de Albuquerque, Hideyoshi Harashima	2014	4
7	An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells Biomaterials ·Amelia Maria Brito de Albuquerque, Takashi Matsuda, Mamoru Hyodo, Yu Sakurai, Hiroto Hatakeyama, Noritaka Ohga, Kyoko Hida, Hideyoshi Harashima	2014	58
8	A new adjuvant delivery system ‘cyclic di-GMP/YSK05 liposome’ for cancer immunotherapy Journal of Controlled Release ·Innocent Sifelani, Mamoru Hyodo, Takashi Nakamura, Yusuke Sato, Yoshihiro Hayakawa, Hideyoshi Harashima	2014	139
9	A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication Journal of Controlled Release ·Md. Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, Mamoru Hyodo, Hideyoshi Harashima	2013	47
10	Saliva collection by using filter paper for measuring cortisol levels in dogs Domestic Animal Endocrinology ·Marisol Claudina Quilumbaquin Chicaiza, Mamoru Hyodo, Hirokazu Doi, Chris Sherratt, Bolin Hu, Satoshi Koyama, Toshiyuki Satoh, Gen Watanabe	2013	14
11	A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo Journal of Controlled Release ·Yusuke Sato, Hiroto Hatakeyama, Yu Sakurai, Mamoru Hyodo, Hidetaka Akita, Hideyoshi Harashima	2012	265
12	STING is a direct innate immune sensor of cyclic di-GMP Nature ·Dara Burdette, Kathryn M. Monroe, Katia Troha, Elsa De Armas Bermúdez, Barbara Eckert, Mamoru Hyodo, Yoshihiro Hayakawa, Russell E. Vance Hit paper breakdown →	2011	1227
13	Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue Journal of Controlled Release ·Md. Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, Mamoru Hyodo, Janina Endriukaitienė, Hideyoshi Harashima	2010	79
14	c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection Vaccine ·Dong‐Liang Hu, Kouji Narita, Mamoru Hyodo, Yoshihiro Hayakawa, Akio Nakane, David K.R. Karaolis	2009	61
15	Multiple activities of c-di-GMP in Pseudomonas aeruginosa Nucleic Acids Symposium Series ·Stephen Lory, Massimo Merighi, Mamoru Hyodo	2009	25
16	c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection Vaccine ·Abiodun D. Ogunniyi, James C. Paton, Alun C. Kirby, Jonathan A. McCullers, A. Poon-King, Mamoru Hyodo, Yoshihiro Hayakawa, David K.R. Karaolis	2008	65
17	Synthesis of Cyclic Bis(3′‐5′)‐2′‐deoxyguanylic/guanylic Acid (c‐dGpGp) and Its Biological Activities to Microbes ChemMedChem ·I. Narsky, Mamoru Hyodo, Shourya Nagaria, Elena Grechi, Michio Ohta, Yoshihiro Hayakawa	2007	11
18	Genome-wide Transcriptional Profile of Escherichia coli in Response to High Levels of the Second Messenger 3′,5′-Cyclic Diguanylic Acid Journal of Biological Chemistry ·L Zulueta-nocedo, Mamoru Hyodo, Yoshihiro Hayakawa, Jorge Membrillo‐Hernández	2006	93
19	Chemical behavior of bis(3′–5′)diguanylic acid in aqueous solutions Nucleic Acids Symposium Series ·Mamoru Hyodo, Shourya Nagaria, Yoshihiro Hayakawa, David K.R. Karaolis	2005	9
20	3′,5′-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation Biochemical and Biophysical Research Communications ·David K.R. Karaolis, Kunrong Cheng, Michael Lipsky, Ahmed Elnabawi, Jennifer Catalano, Mamoru Hyodo, Yoshihiro Hayakawa, Jean‐Pierre Raufman	2005	86

About Mamoru Hyodo

Mamoru Hyodo is a scholar working on Endocrinology, Microbiology, Immunology, Molecular Biology and Infectious Diseases, having authored 88 papers that have together received 7.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (18 papers), Advanced biosensing and bioanalysis techniques (16 papers), DNA and Nucleic Acid Chemistry (11 papers), Bacterial biofilms and quorum sensing (11 papers), Immune Response and Inflammation (9 papers), interferon and immune responses (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Bacterial Genetics and Biotechnology (7 papers). The work is most often cited by research in Immunology (3.3k citations), Endocrinology (652 citations), Molecular Medicine (437 citations), Infectious Diseases (1.5k citations) and Microbiology (456 citations). Mamoru Hyodo has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Yoshihiro Hayakawa, Hideyoshi Harashima, Kathryn M. Monroe, Russell E. Vance, Dara Burdette, Yusuke Sato, Stephen Lory, Katia Troha, Barbara Eckert and Vincent T. Lee. Their work appears in journals such as Journal of Controlled Release, Biological and Pharmaceutical Bulletin, Tetrahedron, Molecular Therapy and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact